Back
Apellis Pharmaceuticals Vs. Regencell Bioscience Holdings Industry Stock Comparison
Buy
60
APLS
Apellis Pharmaceuticals
Last Price:
$23.51
Seasonality Move:
-5.27%
Sell
24
RGC
Regencell Bioscience Holdings
Last Price:
$12.75
Seasonality Move:
-8.63%
Buy
60
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $24.20. The Score for APLS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $13.46. The Score for RGC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $24.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $13.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing slight buying pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.13 | Buy |
Relative Strength Index (14 RSI): | 75.14 | Buy |
Chaikin Money Flow: | -193477 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.03 - 21.59) | Buy |
Bollinger Bands (100): | (17.25 - 21.89) | Buy |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.56 | Buy |
Relative Strength Index (14 RSI): | 44.79 | Sell |
Chaikin Money Flow: | 40010 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.65 - 17.43) | Sell |
Bollinger Bands (100): | (-1.2 - 24.06) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.26 | Buy |
20-day SMA: | 20.3 | Buy |
50-day SMA: | 19.02 | Buy |
200-day SMA: | 24.62 | Sell |
8-day EMA: | 22.05 | Buy |
20-day EMA: | 20.6 | Buy |
50-day EMA: | 19.75 | Buy |
200-day EMA: | 25 | Sell |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.82 | Sell |
20-day SMA: | 14.52 | Sell |
50-day SMA: | 19.81 | Sell |
200-day SMA: | 5.78 | Buy |
8-day EMA: | 10.55 | Buy |
20-day EMA: | 6.13 | Buy |
50-day EMA: | 2.9 | Buy |
200-day EMA: | 0.79 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $1.11 per share, an increase this year of $1.21 per share, and a decrease next year of $0.63 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |